Danielle Sullivan
- Cancer Research top 5%
- Breast Cancer Treatment Studies 3
- Oncology top 5%
- PARP inhibition in cancer therapy 10
- Cancer Treatment and Pharmacology 4
- Cognitive Neuroscience top 10%
- Pathology and Forensic Medicine top 10%
-
- BRCA gene mutations in cancer 5
-
- Ovarian cancer diagnosis and treatment 5
-
- Lung Cancer Treatments and Mutations 4
-
- DNA Repair Mechanisms 3
-
- Lipoproteins and Cardiovascular Health 3
- Co-authors
- David MaagMark D. McKeeCharles E. GeyerSibylle LoiblMehra GolshanOtto MetzgerGϋnter von MinckwitzJozsef Csicsvari
- Journals
- Journal of Clinical Oncology (6 papers)Journal of Hepatology (2 papers)Journal of Thoracic Oncology (2 papers)
- Partner nations
- United StatesGermanySpain
In The Last Decade
Danielle Sullivan
27 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Cancer Research 389
- Oncology 690
- Cellular and Molecular Neuroscience 192
- Cognitive Neuroscience 199
- Pathology and Forensic Medicine 129
Countries citing papers authored by Danielle Sullivan
This map shows the geographic impact of Danielle Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danielle Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danielle Sullivan more than expected).
Fields of papers citing papers by Danielle Sullivan
This network shows the impact of papers produced by Danielle Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danielle Sullivan. The network helps show where Danielle Sullivan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Danielle Sullivan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 7 | |
| 2 | 2021 | 10 | |
| 3 | 2021 | 9 | |
| 4 | 2020 | 1 | |
| 5 | 2020 | 1 | |
| 6 | 2020 | 2 | |
| 7 | 2019 | 7 | |
| 8 | 2018 | 47 | |
| 9 | 2018 | 58 | |
| 10 | Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trialbreakdown → | 2018 | 516 |
| 11 | 2018 | 1 | |
| 12 | 2018 | 14 | |
| 13 | 2017 | 7 | |
| 14 | 2016 | 47 | |
| 15 | 2015 | 2 | |
| 16 | 2015 | 7 | |
| 17 | 2013 | 23 | |
| 18 | Abstract 12621: Efficacy and Tolerability of Long-Term Treatment With AMG 145 in Patients With Statin Intolerance | 2013 | 2 |
| 19 | 2011 | 218 | |
| 20 | A multicenter double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesteremia | 1997 | 1 |
About Danielle Sullivan
Danielle Sullivan is a scholar working on Reproductive Medicine, Oncology, Hepatology, Genetics and Cancer Research, having authored 27 papers that have together received 1.1k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (10 papers), BRCA gene mutations in cancer (5 papers), Ovarian cancer diagnosis and treatment (5 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (4 papers), DNA Repair Mechanisms (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Cancer Research (389 citations), Oncology (690 citations), Cellular and Molecular Neuroscience (192 citations), Cognitive Neuroscience (199 citations) and Pathology and Forensic Medicine (129 citations). Danielle Sullivan has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include David Maag, Mark D. McKee, Charles E. Geyer, Sibylle Loibl, Mehra Golshan, Otto Metzger, Gϋnter von Minckwitz, Jozsef Csicsvari, György Buzsáki and Norman Wolmark. Their work appears in journals such as Journal of Clinical Oncology, Journal of Hepatology, Journal of Thoracic Oncology, Gynecologic Oncology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.